- Home
- MRK vs CXAIW Comparison
MRK vs CXAIW Comparison
Compare MRK & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | CXAIW |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | N/A |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | CXAIW |
|---|---|---|
| Price | $113.51 | $0.05 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $124.29 | N/A |
| AVG Volume (30 Days) | ★ 7.2M | 47.5K |
| Earning Date | 04-23-2026 | 03-21-2025 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | $7,200,000.00 |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | $15.70 | ★ N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $0.02 |
| 52 Week High | $125.14 | $0.16 |
Technical Indicators
Market Signals| Indicator | MRK | CXAIW |
|---|---|---|
| Relative Strength Index (RSI) | 40.17 | 47.85 |
| Support Level | $105.23 | $0.03 |
| Resistance Level | $125.14 | $0.08 |
| Average True Range (ATR) | 2.48 | 0.01 |
| MACD | -0.82 | -0.00 |
| Stochastic Oscillator | 11.52 | 30.04 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About CXAIW CXApp Inc. Warrant
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.